QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Cosmetic makers must reveal hidden ingredients and hazards to consumers

H.R. 4435 — Cosmetic Hazardous Ingredient Right to Know Act of 2025 · Filed by Jan Schakowsky (D-IL) · 13 cosponsors · Introduced Jul 16, 2025 · Referred to committee

85%
Transparency
Typical bill: 82%
15/100
Hidden-provision risk
Typical bill: 15/100
Consumer Transparency & Product Safety

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill requires cosmetic manufacturers to disclose all ingredients—including fragrance and flavor components—on product websites within one year and on physical packaging within two years. It mandates that products containing hazardous chemicals (carcinogens, reproductive toxicants, persistent bioaccumulatives, and others identified by EPA, CDC, and international agencies) carry a warning label directing consumers to the brand's website for health information. States retain authority to impose stricter requirements.

Why we flagged it

The bill's operative mechanism is mandatory disclosure of cosmetic ingredients and hazard warnings to consumers. It does not ban substances, impose new safety standards, or create liability—it requires transparency. The functional character is information access, not prohibition or restriction.

What the text implies

  • Fragrance and flavor ingredients, historically protected as trade secrets under the 'fragrance loophole,' are now subject to disclosure. This may expose proprietary formulations but serves consumer health transparency.
  • The bill references 22 separate hazard lists (EPA, CDC, California, EU, WHO, etc.), creating a dynamic master list maintained by FDA. Manufacturers must update disclosures within 7 months of list changes, imposing ongoing compliance burden.

The full analysis lists 5 implications of this text.

Who it affects

Consumers gain transparency about cosmetic ingredients and hazard exposure, enabling informed choice and reducing information asymmetry. Manufacturers bear compliance costs (ingredient disclosure, website updates, labeling), but these are passed through normal market channels and do not restrict consumer rights or remedies.

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record